Skip to content
Lower risk Medical device recall · FDA · Published September 3, 2021

Roche cobas EGFR Mutation Test v2 may give false results for Ex20Ins mutations

Roche recalls cobas EGFR Mutation Test v2 due to false mutation results for Ex20Ins mutations, potentially leading to incorrect cancer treatment decisions. Affected units include all lot numbers of the system.

🇺🇸 FDA recall #Z-0083-2022Medical deviceRoche ›
Take action

Contact the company

Recalling firmRoche Molecular Systems, Inc.1080 US Highway 202 S · Branchburg, NJ 08876-3733
✎ GovInfoNow plain-language explainer

Roche is recalling its cobas EGFR Mutation Test v2 system because it can produce false results for Ex20Ins mutations, which might lead to incorrect cancer treatments. This affects all units of the system sold with the catalog number 07248563190. Read more at govinfonow.com/recall/61832-roche-cobas-egfr-mutation-test-v2-may-give-false-results.

Source Summary by GovInfoNow · govinfonow.com/recall/61832-roche-cobas-egfr-mutation-test-v2-may-give-false-results · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0083-2022

Cite this page

“Roche cobas EGFR Mutation Test v2 may give false results for Ex20Ins mutations.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61832-roche-cobas-egfr-mutation-test-v2-may-give-false-results. Based on FDA recall #Z-0083-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0083-2022%22&limit=1).

Roche Molecular Systems, Inc. recalled the cobas EGFR Mutation Test v2-Somatic gene mutation detection system (Catalog Number 07248563190) on Sept. 3, 2021, according to the FDA. The device may produce false mutation detected results for exon 20 insertion mutations, potentially leading to inappropriate treatment.

How to tell if you have it

  • Brand: Roche
  • Product: cobas EGFR Mutation Test v2-Somatic gene mutation detection system
  • Catalog Number: 07248563190
  • Lot numbers: All lot numbers

The hazard

The recall cites a hazard where the cobas EGFR Mutation Test v2 may detect false mutations for the exon 20 insertion (Ex20Ins), which may lead to inappropriate treatment. The official record does not report specific incidents or injuries.

Context

GovInfoNow's records show Roche Molecular Systems, Inc. has 10 other recalls on record since Oct. 27, 2017. Other recent recalls of similar products include the Roche cobas SARS-CoV-2 & Flu A/B tests (Dec. 21, 2022), the Roche cobas 5800 PCR device (Sept. 8, 2022), and the Roche cobas LiatSystem (Nov. 16, 2021). Additional recent recalls of similar products include the Roche cobas pro integrated solutions (Jan. 20, 2026), the Roche Elecsys Anti-TSHR Assay (Nov. 21, 2025), and the Exploro Fertility Test (Nov. 22, 2025).

How to tell if you have this one

Check for the cobas EGFR Mutation Test v2 system with catalog number 07248563190. All lot numbers are affected by this recall.

  • Brand
    Roche
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the catalog number 07248563190 on the system to confirm if it is affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide distribution and the countries of Canada, UK, Poland, Spain, Italy, Sweden, Greece, Denmark, Norway, Netherlands, France, Czech Republic, Belgium, Austria, Slovakia, Hungary, Switzerland, Lithuania,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 47 days after the firm started it.

1. Firm started the recall: Sep 3, 202112. FDA classified it Class II: Oct 8, 202123. Published in FDA’s Enforcement Report: Oct 20, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0083-2022 (September 3, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0083-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA